Tower Research Capital LLC (Trc) Journey Medical Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Journey Medical Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,923 shares of DERM stock, worth $16,251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,923
Previous 761
284.1%
Holding current value
$16,251
Previous $4,000
175.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DERM
# of Institutions
41Shares Held
4.66MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.73MShares$9.59 Million0.53% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.81 Million0.36% of portfolio
-
Cambridge Investment Research Advisors, Inc.328KShares$1.82 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.81 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny236KShares$1.31 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $64.5M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...